These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 3818947

  • 1. Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure.
    Malluche HH, Faugere MC, Friedler RM, Matthews C, Fanti P.
    J Clin Invest; 1987 Mar; 79(3):754-61. PubMed ID: 3818947
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Attenuated bone aluminum deposition in nonuremic beagles with reduced bone remodeling.
    Quarles LD.
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E576-81. PubMed ID: 2333958
    [Abstract] [Full Text] [Related]

  • 4. Parathyroid hormone and 1,25(OH)2D3 in chronic renal failure.
    Feinfeld DA, Sherwood LM.
    Kidney Int; 1988 Jun; 33(6):1049-58. PubMed ID: 2841530
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs.
    Quarles LD, Dennis VW, Gitelman HJ, Harrelson JM, Drezner MK.
    J Clin Invest; 1985 May; 75(5):1441-7. PubMed ID: 3998143
    [Abstract] [Full Text] [Related]

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 8. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
    Coen G, Mazzaferro S, Costantini S, Ballanti P, Carrieri MP, Giordano R, Smacchi A, Sardella D, Bonucci E, Taggi F.
    Miner Electrolyte Metab; 1989 Nov; 15(5):295-302. PubMed ID: 2811788
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Relationships between calcium and phosphorus homeostasis, parathyroid hormone levels, bone aluminum, and bone histomorphometry in patients on maintenance hemodialysis.
    Nilsson P, Melsen F, Malmaeus J, Danielson BG, Mosekilde L.
    Bone; 1985 Nov; 6(1):21-7. PubMed ID: 2581596
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of childhood renal osteodystrophy with calcitriol or ergocalciferol.
    Hodson EM, Evans RA, Dunstan CR, Hills E, Wong SY, Rosenberg AR, Roy LP.
    Clin Nephrol; 1985 Oct; 24(4):192-200. PubMed ID: 3877585
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.